| Autor: |
Fernando Cairo, Lucia Navarro, Nicolas Dominguez, Ignacio Roca, Omar Galdame, Laura Gonzalez, Lucia Guillen, Stella Loudet, Manuel Barbero |
| Jazyk: |
angličtina |
| Rok vydání: |
2024 |
| Předmět: |
|
| Zdroj: |
Annals of Hepatology, Vol 29, Iss , Pp 101609- (2024) |
| Druh dokumentu: |
article |
| ISSN: |
1665-2681 |
| DOI: |
10.1016/j.aohep.2024.101609 |
| Popis: |
Conflict of interest: No Introduction and Objectives: Patients diagnosed with viral hepatitis often fail to follow up, a problem exacerbated by the pandemic. The ''relink'' strategy aims to reconnect these patients to ensure they receive the necessary follow-up and treatment.The objective of our work was to generate a PANRELINK program based on the analysis of blood samples tested for HBsAg and anti-HCV antibodies from the reference laboratory database at Hospital El Cruce and to implement a relink strategy for patients with positive results. Patients / Materials and Methods: We analyzed the results of blood samples tested for HBsAg and HCV antibodies by chemiluminescence, conducted at the reference laboratory from 2012 to 2022. Samples were stratified by origin (primary care centers [CAP] vs. medium and high complexity hospitals [MHC]). Statistical analyses chi-squared and t-tests. Results and Discussion: A total of 108,261 blood samples were tested for HBsAg, with a test positivity rate (TPR) of 0.28% (306/108,261). For HCV, 106,917 samples were tested, with a TPR of 1.09% (1,162/106,917). When stratified by sample origin, TPR for HBsAg was 0.11% (101/86,609) in CAP and 0.96% (205/21,652) in MHC (p |
| Databáze: |
Directory of Open Access Journals |
| Externí odkaz: |
|
